SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-009796
Filing Date
2022-05-13
Accepted
2022-05-13 07:42:06
Documents
7
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A oncr_def_14a_-_2022_prox.htm DEF 14A 1090687
2 GRAPHIC img187557102_0.jpg GRAPHIC 64798
3 GRAPHIC img187557102_1.jpg GRAPHIC 27145
4 GRAPHIC img187557102_2.jpg GRAPHIC 22629
5 GRAPHIC img187557102_3.jpg GRAPHIC 22629
6 GRAPHIC img187557102_4.jpg GRAPHIC 81815
7 GRAPHIC img187557102_5.jpg GRAPHIC 82017
  Complete submission text file 0000950170-22-009796.txt   1487515
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39575 | Film No.: 22920262
SIC: 2834 Pharmaceutical Preparations